Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 28'th May 2026
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
01:26pm, Thursday, 21'st May 2026
OPKO Health leans on RAYALDEE and key partnerships, such as BioReference and 4Kscore, as it ramps toward mid-2026 diagnostics breakeven.
Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell depletion in animal models Data will be presented at the American Society of Gene & Cell Th
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
08:30am, Thursday, 30'th Apr 2026
MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced that its subsidiary EirGen Pharma Limited (EirGen) has entered into an amendment to its agreement with
ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the la
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
02:02pm, Wednesday, 29'th Apr 2026
OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a smaller BioReference diagnostics base.
OPKO Health, Inc. (OPK) Q1 2026 Earnings Call Transcript
10:51pm, Tuesday, 28'th Apr 2026
OPKO Health, Inc. (OPK) Q1 2026 Earnings Call Transcript
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
08:01pm, Tuesday, 28'th Apr 2026
Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Stre
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
08:00pm, Tuesday, 28'th Apr 2026
OPKO Health (OPK) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago.
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
04:05pm, Tuesday, 28'th Apr 2026
MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first
Financial Survey: OrthoPediatrics (NASDAQ:KIDS) and OPKO Health (NASDAQ:OPK)
04:18am, Friday, 24'th Apr 2026
OrthoPediatrics (NASDAQ: KIDS - Get Free Report) and OPKO Health (NASDAQ: OPK - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companie
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
01:11pm, Thursday, 23'rd Apr 2026
OPKO Health rides on RAYALDEE strength, partnerships and restructuring gains, but reliance on a single drug keeps risk in focus for investors.
OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
08:00am, Wednesday, 22'nd Apr 2026
Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
04:05pm, Tuesday, 21'st Apr 2026
MIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2026 after the close of the U.S. financia
Comparing OPKO Health (NASDAQ:OPK) & ADM Tronics Unlimited (OTCMKTS:ADMT)
01:44am, Friday, 17'th Apr 2026
OPKO Health (NASDAQ: OPK - Get Free Report) and ADM Tronics Unlimited (OTCMKTS:ADMT - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the tw
